title: Topical immunotherapy in the treatment of chronic severe alopecia areata.
abstract: In the past decade, topical immunotherapy with DPCP has been shown to be a very important therapeutic modality in the treatment of chronic severe alopecia areata. At the University of British Columbia Hair Clinic, it is our treatment of choice in adults. This option for treatment should be offered to the appropriate patients.
authors.affiliation: Hair Clinic, University of British Columbia, Vancouver, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Shapiro
mesh_terms: D000287:Administration, Topical; D000485:Allergens / Q000008:administration & dosage; D000506:Alopecia Areata / Q000628:therapy*; D002908:Chronic Disease; D003503:Cyclobutanes / Q000008:administration & dosage / Q000009:adverse effects; D003521:Cyclopropanes / Q000008:administration & dosage / Q000009:adverse effects; D004137:Dinitrochlorobenzene / Q000008:administration & dosage / Q000009:adverse effects; D006197:Hair / Q000254:growth & development; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods
chemical_list: D000485:Allergens; D003503:Cyclobutanes; D003521:Cyclopropanes; D004137:Dinitrochlorobenzene; C020637:squaric acid dibutyl ester; C029402:diphenylcyclopropenone